Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Dova Pharmaceuticals, Inc. (DOVA)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-18Dec-31-17
   10-K10-K
Revenues  11.50.0
Cost of goods sold  1.20.0
Gross profit  10.40.0
            Gross margin  89.8% 
Selling, general and administrative  61.913.5
Research and development  18.315.7
Other operating expenses  1.2 
EBITDA   [+]-71.0 
            EBITDA margin  -615.7% 
Depreciation and amortization  0.0 
EBIT   [+]-71.1-29.2
            EBIT margin  -616.0% 
Interest expense  1.91.2
Other income (expense), net  0.60.5
Pre-tax income  -72.3-30.0
Income taxes  0.00.0
            Tax rate  0.0%0.0%
Net income  -72.3-30.0
            Net margin  -626.6% 
   
Basic EPS   [+]($2.60)($1.40)
Diluted EPS   [+]($2.60)($1.40)
   
Shares outstanding (basic)   [+]27.821.4
Shares outstanding (diluted)   [+]27.821.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy